Hyperlipidaemias Flashcards

1
Q

Name some statins.

A
  • Atorvastatin

- Simvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism of action of statins.

A
  • Competitive inhibition of HMG-CoA reductase.

- Upregulation of LDL receptors so increased clearance of LDL occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Side effects of statins

A
  • GI disruption
  • Myalgia (therefore, check CPK levels)

Adjust dose based off side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Avoid the use of statins in patients with:

A
  • Renal impairment

- Pregnancy and breast feeding as cholesterol is required for development of fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Contraindications of statins

A
  • CYP3A4 inhibitors = amiodarone, diltiazem, macrolides, amlodipine is a weak inhibitor so can be given with high dose statin.
  • Avoid grape fruit juice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the first line statin prescribed and why?

A
  • Atorvastatin because it reduces LDL levels greater for over the same period of time compared to simvastatin. Also has a longer half life.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When should simvastatin be prescribed to be used for?

A
  • Used at night because it has a shorter half life so it’s efficacy would be maximised as increased cholesterol production at night.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is treatment and allocation of dose based off to treat hyperlipidaemia?

A
  • QRISK score >10% to see the risk of CVD in the next 10 years.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Additional benefits of statin therapy?

A
  • Decreased CVD risk
  • Improved vascular endothelial function by increasing NO and VEGF and decreasing endothelin.
  • Stabilisation of atherosclerotic plaque - decreased SMC proliferation and increased collagen.
  • Improved Haemostasis by decreasing plasma fibrinogen, platelet aggregation and increasing fibrinolysis.
  • Anti-inflammatory decreasing proliferation of inflammatory cells into plaque
  • Antioxidant which reduces superoxide formation so less ROS = less foam cell production = less fatty streak production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name a fibrates and it’s mechnism of action

A
  • Fenofibrate
  • Actives PPAR alpha which regulates gene expression - increased LPL expression.
  • Increased FA brought to liver and increased TAG in plasma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side effects of fibrates.

A
  • Cholelithiasis As fibrates decrease bile acid excretion

- Myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindication of fibrates

A
  • Warfarin - gets potentiated so increased bleeding.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are fibrates co-prescribed with?

A
  • Statin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name a cholesterol absorption inhibitor

A
  • Ezetimibe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of action of Ezetimibe

A
  • Inhibits NPC1L1 in brush border of small intestine resulting in decreased absorption of cholesterol by 50%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the metabolism of cholesterol absorption inhibitors.

A
  • They are pro-drugs that get activated in the liver and remain in the entero-hepatic circulation.
  • Since it remains in the GI, very few ADRs.
17
Q

Side effects of cholesterol absorption inhibitors.

A
  • Abdo pain

- GI upset

18
Q

Avoid the cholesterol absorption inhibitors in patients with:

A
  • Hepatic failure
19
Q

Which prescription regime will potentiate the effect of cholesterol absorption inhibitors?

A
  • If it is co-prescribed with a statin at a low dose = decreased CVD more than a statin would alone.
20
Q

Name PCSK9 inhibitors.

A
  • Alirocumab

- Evolocumab

21
Q

Mechanism of action of PCSK9 inhibitor

A
  • Prevents LDL receptor internalisation and lysosomal degradation of the receptor. So increased LDL receptor expression = increased clearance or LDL from plasma.
22
Q

Why are PCSK9 inhibitors not prescribed more frequently?

A
  • They are an expensive depo injection.